Kempner Capital Management’s Quest Diagnostics DGX Stock Holding History

Kempner Capital Management’s Portfolio DGX Stock Details DGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-15,975	Closed	-$1.3M	–	69
2016 Q2	$1.3M	Hold	15,975	–	–	0.84%	37
2016 Q1	$1.14M	Hold	15,975	–	–	0.69%	41
2015 Q4	$1.14M	Sell	15,975 -345	-2%	-$23.2K	0.67%	41
2015 Q3	$1M	Hold	16,320	–	–	0.57%	44
2015 Q2	$1.18M	Sell	16,320 -9,815	-38%	-$725K	0.62%	43
2015 Q1	$2.01M	Sell	26,135 -8,900	-25%	-$637K	1.28%	34
2014 Q4	$2.35M	Hold	35,035	–	–	1.06%	39
2014 Q3	$2.13M	Sell	35,035 -1,900	-5%	-$117K	0.9%	40
2014 Q2	$2.17M	Hold	36,935	–	–	0.86%	40
2014 Q1	$2.14M	Buy	+36,935	New	+$1.98M	0.87%	37

Other funds holding DGX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Kempner Capital Management's DGX Position: Q3 2016 in Review

Kempner Capital Management sold out of Quest Diagnostics (DGX) in Q3 2016, closing a stake of 15,975 shares — an estimated $1.3M sold.

Kempner Capital Management first reported a position in DGX in Q1 2014 and held it in 10 quarters. The position peaked at $2.35M in Q4 2014. 559 funds tracked by Wall St. Rank hold DGX as of Q3 2016.

Kempner Capital Management reported no remaining Quest Diagnostics position as of Q3 2016 after selling out during the quarter.
Kempner Capital Management sold 15,975 Quest Diagnostics shares in Q3 2016, an estimated $1.3M.
Kempner Capital Management first reported a position in Quest Diagnostics in Q1 2014 and held it in 10 quarters.
Kempner Capital Management's Quest Diagnostics position peaked at $2.35M in Q4 2014.
559 funds tracked by Wall St. Rank held Quest Diagnostics as of Q3 2016.

Based on Kempner Capital Management's 13F filing for Q3 2016, filed 4 Oct 2016.